What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
about
Tenascin-X is a novel diagnostic marker of malignant mesotheliomaMesothelin targeted cancer immunotherapyMalignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical featuresThe carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in ratsDevelopment of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patientsExpression of mesothelioma-related markers in meningiomas: an immunohistochemical studyEstablishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: Does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells?Investigational approaches for mesothelioma.Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.Identification of novel markers for the diagnosis of malignant pleural mesothelioma.The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.Calretinin as a blood-based biomarker for mesotheliomaAdult human sarcomas. I. Basic science.Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature.Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature.Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosisNew diagnostic and molecular characteristics of malignant mesothelioma.Diagnosis and management options in malignant pleural effusions.Systemic lymphadenopathy as the initial presentation of malignant mesothelioma: a report of three cases.Primary pleural epithelioid mesothelioma of clear cell type: a case report and review of current literature.Deciduoid mesothelioma: report of 21 cases with review of the literature.Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions: thirty-eight cases confirmed with paired box-8 immunohistochemical staining and correlation with surgical biopsy findings.Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma.Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.Localized malignant myxoid anaplastic mesothelioma of the pericardium.Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer.A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.Pleural effusion: what lies underneath?Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology.Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.Amatuximab and novel agents targeting mesothelin for solid tumors.Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions.Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.Sarcoma and look-alikes: the important role of ultrastructural evaluation.Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases.
P2860
Q24649948-1B95E2B1-9B98-449F-B9C5-A0E3211F1DABQ24656242-1447721F-5DF9-43AB-B755-8632F0CD0EFAQ27024213-4979A6FD-4347-47AE-BA7B-D9F360812694Q28382993-A7E646CA-633B-45B7-B2B3-802E7151C90CQ33590140-4238A153-6C11-4A13-AA1D-71BA165A9D06Q33615599-7BF54C25-8567-4B37-8FF7-1B808D0BD352Q34072810-4F64858D-6B2E-4051-9CF4-3D3491445924Q34170173-1EE363F6-BA8D-4EF1-8611-63E009EA953CQ34293068-C93FD44B-31CF-47F9-9877-E438938D7876Q34646018-197C8E98-621F-4045-96E7-929A8194A8ECQ34760760-B52A4B1E-D36B-4444-8996-3AAEB8AF5A90Q35232383-60D1F31F-D0C9-43DC-AAB2-5F21101DEAFFQ35576881-22B09C32-3EF7-43D8-B6D1-EAFC6CFC4F09Q36385172-D624CF0C-D6B1-4C2D-89EF-6FD7EFB2D52AQ36691805-3757AF93-D385-4C13-8AB6-F119D7490FDCQ36741786-36A31731-00CC-43BB-BB9B-5333C4D89869Q36980801-F9AB1841-817E-4404-B75E-AC62684D4AC8Q37122303-8362F923-14F3-44AB-B02F-5109421E1008Q37360580-C26807D5-9AF7-42BD-A96E-7FA918C66D4AQ37701196-DCAA926A-2623-46F8-B034-3F070EA167E8Q37820130-362D0D9F-EED7-40D4-87B8-616434C2D46EQ37943004-59A76191-4949-4DA4-ABD9-7BCC2D5C09D8Q38017572-C8BE1971-18BA-4FF0-9C5C-3FC84C789AB4Q38060678-F69B46DF-6C55-4E79-9F8A-08A780FB4949Q38106920-DF31AB7F-76F6-41F5-AFC0-40EB8D8923BAQ38994020-6CE80D48-94E8-4468-AE59-6303C6AF1032Q39298123-AEA17FCE-B492-4282-9E5C-891CA3157FDEQ41968662-6A4143D7-75BF-412C-B81E-8463886E1E10Q42142646-84ACDDF7-9011-4F60-A2CE-F9B837744C4AQ42398312-90C7835F-0DB8-42C8-A507-0B7F7BAD42B6Q42582696-0B3F66C4-785E-421A-BA27-B1FA1A22DE33Q43299881-1130DBB1-4B26-431B-A8DC-B2A58C94FA34Q43973010-F2649222-5453-43B1-B8A5-8F88AD63D81FQ44173242-A8ED2826-0504-4A16-BCD5-7717375BB600Q46891964-524E14B5-315F-40BE-9FDD-74BB03EDEA78Q47126660-63B3A7EF-E241-46C0-B49A-31F34B89FC52Q47672873-7DEC3B9B-7E6E-4EC4-A3B9-3324FE48B91BQ48579071-F27DA239-C3F4-4117-86C7-A8686DD2BB21Q50793545-75A373E2-DD82-4C8B-9367-2B928F9B05C1Q51630774-F64344F6-248A-4BBC-9C79-FFB578BA6003
P2860
What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
What are the current best immu ...... thelioma? A review and update.
@ast
What are the current best immu ...... thelioma? A review and update.
@en
type
label
What are the current best immu ...... thelioma? A review and update.
@ast
What are the current best immu ...... thelioma? A review and update.
@en
prefLabel
What are the current best immu ...... thelioma? A review and update.
@ast
What are the current best immu ...... thelioma? A review and update.
@en
P1433
P1476
What are the current best immu ...... thelioma? A review and update.
@en
P2093
Nelson G Ordóñez
P356
10.1016/J.HUMPATH.2006.08.010
P407
P577
2006-10-23T00:00:00Z